2 chapters across the catalog
Ozempic and Wagovy have become viral sensations for off-label weight loss, despite being designed for type 2 diabetes management. The hosts discuss the pharmaceutical industry's marketing strategies and potential long-term side effects, including pancreatitis and gastrointestinal issues.
The FDA's review of Qnexa, a weight loss pill combining seizure medication with phentermine, highlights the pharmaceutical industry's habit of repackaging old drugs. Phentermine was half of the original Fen-Phen cocktail, raising safety concerns about heart-related side effects.
